213 related articles for article (PubMed ID: 32034058)
1. Integrated characterisation of cancer genes identifies key molecular biomarkers in stomach adenocarcinoma.
Wang H; Shen L; Li Y; Lv J
J Clin Pathol; 2020 Sep; 73(9):579-586. PubMed ID: 32034058
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of cancer driver genes in prostate adenocarcinoma.
Zhao X; Lei Y; Li G; Cheng Y; Yang H; Xie L; Long H; Jiang R
Mol Med Rep; 2019 Apr; 19(4):2707-2715. PubMed ID: 30720096
[TBL] [Abstract][Full Text] [Related]
3. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid Cancer.
Xu Q; Song A; Xie Q
Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatic analysis of the prognostic value of ZNF860 in recurrence-free survival and its potential regulative network in gastric cancer.
Pan HX; Bai HS; Guo Y; Cheng ZY
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):162-170. PubMed ID: 30767193
[TBL] [Abstract][Full Text] [Related]
5. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
Li X; Pasche B; Zhang W; Chen K
JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
[TBL] [Abstract][Full Text] [Related]
6. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value and Immune Infiltrates of ABCA8 and FABP4 in Stomach Adenocarcinoma.
Guo Y; Wang ZW; Su WH; Chen J; Wang YL
Biomed Res Int; 2020; 2020():4145164. PubMed ID: 32685482
[TBL] [Abstract][Full Text] [Related]
8. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
Zang ZJ; Cutcutache I; Poon SL; Zhang SL; McPherson JR; Tao J; Rajasegaran V; Heng HL; Deng N; Gan A; Lim KH; Ong CK; Huang D; Chin SY; Tan IB; Ng CC; Yu W; Wu Y; Lee M; Wu J; Poh D; Wan WK; Rha SY; So J; Salto-Tellez M; Yeoh KG; Wong WK; Zhu YJ; Futreal PA; Pang B; Ruan Y; Hillmer AM; Bertrand D; Nagarajan N; Rozen S; Teh BT; Tan P
Nat Genet; 2012 May; 44(5):570-4. PubMed ID: 22484628
[TBL] [Abstract][Full Text] [Related]
9. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
10. Differences in the histological findings, phenotypic marker expressions and genetic alterations between adenocarcinoma of the gastric cardia and distal stomach.
Tajima Y; Yamazaki K; Makino R; Nishino N; Masuda Y; Aoki S; Kato M; Morohara K; Kusano M
Br J Cancer; 2007 Feb; 96(4):631-8. PubMed ID: 17262083
[TBL] [Abstract][Full Text] [Related]
11. An integrated analysis of cancer genes in clear cell renal cell carcinoma.
Li J; Guo L; Ai Z
Future Oncol; 2017 Apr; 13(8):715-725. PubMed ID: 28266251
[TBL] [Abstract][Full Text] [Related]
12. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
Liu N; Wu Y; Cheng W; Wu Y; Wang L; Zhuang L
BMC Cancer; 2021 Apr; 21(1):460. PubMed ID: 33902514
[TBL] [Abstract][Full Text] [Related]
13. Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
Yu Y; Xie Z; Zhao M; Lian X
BMC Cancer; 2021 Apr; 21(1):368. PubMed ID: 33827485
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenia and a 5-mRNA risk module as a combined factor to predict prognosis for patients with stomach adenocarcinoma.
Yang H; Tian W; Zhou B
Genomics; 2022 Jan; 114(1):361-377. PubMed ID: 34933074
[TBL] [Abstract][Full Text] [Related]
15. Hepatoid adenocarcinoma of the stomach: a unique subgroup with distinct clinicopathological and molecular features.
Wang Y; Sun L; Li Z; Gao J; Ge S; Zhang C; Yuan J; Wang X; Li J; Lu Z; Gong J; Lu M; Zhou J; Peng Z; Shen L; Zhang X
Gastric Cancer; 2019 Nov; 22(6):1183-1192. PubMed ID: 30989433
[TBL] [Abstract][Full Text] [Related]
16. Identification of RFX5 as prognostic biomarker and associated with immune infiltration in stomach adenocarcinoma.
Guo L; Liu D
Eur J Med Res; 2022 Aug; 27(1):164. PubMed ID: 36045400
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of sorting nexin 10 weak expression in stomach adenocarcinoma revealed by weighted gene co-expression network analysis.
Zhang J; Wu Y; Jin HY; Guo S; Dong Z; Zheng ZC; Wang Y; Zhao Y
World J Gastroenterol; 2018 Nov; 24(43):4906-4919. PubMed ID: 30487700
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of microsatellite-instability in gastric and gastroesophageal junction cancer patients undergoing neoadjuvant chemotherapy.
Haag GM; Czink E; Ahadova A; Schmidt T; Sisic L; Blank S; Heger U; Apostolidis L; Berger AK; Springfeld C; Lasitschka F; Jäger D; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2019 Apr; 144(7):1697-1703. PubMed ID: 30499151
[TBL] [Abstract][Full Text] [Related]
19. Increasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
Silva ANS; Saito Y; Yoshikawa T; Oshima T; Hayden JD; Oosting J; Earle S; Hewitt LC; Slaney HL; Wright A; Inam I; Langley RE; Allum W; Nankivell MG; Hutchins G; Cunningham D; Grabsch HI
Br J Surg; 2022 Feb; 109(3):291-297. PubMed ID: 35179206
[TBL] [Abstract][Full Text] [Related]
20. KRAS Mutation in Gastric Cancer and Prognostication Associated with Microsatellite Instability Status.
Polom K; Das K; Marrelli D; Roviello G; Pascale V; Voglino C; Rho H; Tan P; Roviello F
Pathol Oncol Res; 2019 Jan; 25(1):333-340. PubMed ID: 29116623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
